Abstract
AbstractMulticellular 3D biological models, the so-called “-oids”, are the pivot key for the new generation of high-content screening (HCS) of drug analysis, cancer research, and regenerative medicine. However, the standardisation of 3D cell culture generation, handling, imaging, and data analysis remains a challenge and lacks convincing applications. In this work, we propose HCS-3DX, a next-generation system revolutionising HCS research in 3D imaging and evaluation. HCS-3DXis based on three main components: an automated Artificial Intelligence (AI)-driven micromanipulator for oid selection, an engineered HCS foil multiwell plate for optimised imaging, and an image-based software for single-cell data analysis. The developed system was validated through different experiments with 3D tumour models, including tumour-stroma co-cultures. The results prove that the resolution achievable with HCS-3DXenables us to overcome the limitations of current systems and reliably perform 3D high-content screening (HCS) at the single-cell level.
Publisher
Cold Spring Harbor Laboratory
Reference26 articles.
1. Duval, K. , Grover, H. , Han, L. H. , Mou, Y. , Pegoraro, A. F. , Fredberg, J. , & Chen, Z . Modeling physiological events in 2D vs. 3D cell culture. Physiology, 32(4), 266-277 (2017).
2. Concerns, challenges and promises of high-content analysis of 3D cellular models;O. J. T.;Nature reviews Drug discovery,2018
3. Emerging Models of Drug Metabolism, Transporters, and Toxicity
4. The production of 3D tumor spheroids for cancer drug discovery;Drug Discovery Today: Technologies,2017
5. Vogt, N. Assembloids. Nature Methods, 18(1), 27–27 (2021).